The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
RAGE signaling sustains inflammation and promotes tumor development
Open accessAbstract
A broad range of experimental and clinical evidence has highlighted the central role of chronic inflammation in promoting tumor development. However, the molecular mechanisms converting a transient inflammatory tissue reaction into a tumor-promoting microenvironment remain largely elusive. We show that mice deficient for the receptor for advanced glycation end-products (RAGE) are resistant to DMBA/TPA-induced skin carcinogenesis and exhibit a severe defect in sustaining inflammation during the promotion phase. Accordingly, RAGE is required for TPA-induced up-regulation of proinflammatory mediators, maintenance of immune cell infiltration, and epidermal hyperplasia. RAGE-dependent up-regulation of its potential ligands S100a8 and S100a9 supports the existence of an S100/RAGE-driven feed-forward loop in chronic inflammation and tumor promotion. Finally, bone marrow chimera experiments revealed that RAGE expression on immune cells, but not keratinocytes or endothelial cells, is essential for TPA-induced dermal infiltration and epidermal hyperplasia. We show that RAGE signaling drives the strength and maintenance of an inflammatory reaction during tumor promotion and provide direct genetic evidence for a novel role for RAGE in linking chronic inflammation and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1703 · Cited by 3,085
Paradoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256
AP-1: a double-edged sword in tumorigenesis
Eferl, R., & Wagner, E. F. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1209 · Cited by 2,242
RAGE Mediates a Novel Proinflammatory Axis
Hofmann, M. A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80801-6 · Cited by 1,864
Self-citationSmoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
Vogl, T., Tenbrock, K., Ludwig, S., Leukert, N., Ehrhardt, C., van Zoelen, M. A. D., Nacken, W., Foell, D., van der Poll, T., Sorg, C., et al. (2007) · Nature Medicine · doi:10.1038/nm1638 · Cited by 1,418
Understanding RAGE, the receptor for advanced glycation end products
Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D. M., & Nawroth, P. P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0688-7 · Cited by 1,297
Self-citationThe multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
Schmidt, A. M., Yan, S. D., Yan, S. F., & Stern, D. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14002 · Cited by 1,253
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., et al. (2000) · Nature · doi:10.1038/35012626 · Cited by 1,217
Hiratsuka, S., Watanabe, A., Aburatani, H., & Maru, Y. (2006) · Nature Cell Biology · doi:10.1038/ncb1507 · Cited by 1,015
Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis
Moore, R. J., Owens, D. M., Stamp, G., Arnott, C., Burke, F., East, N., Holdsworth, H., Turner, L., Rollins, B., Pasparakis, M., et al. (1999) · Nature Medicine · doi:10.1038/10552 · Cited by 839
Diabetes-Associated Sustained Activation of the Transcription Factor Nuclear Factor-κB
Bierhaus, A., Schiekofer, S., Schwaninger, M., Andrassy, M., Humpert, P. M., Chen, J., Hong, M., Luther, T., Henle, T., Klöting, I., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2792 · Cited by 824
Self-citationS100A8 and S100A9 in inflammation and cancer
Gebhardt, C., Németh, J., Angel, P., & Hess, J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.05.017 · Cited by 696
Self-citationMultistage carcinogenesis in mouse skin
DiGiovanni, J. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90051-z · Cited by 642
Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins
Zenz, R., Eferl, R., Kenner, L., Florin, L., Hummerich, L., Mehic, D., Scheuch, H., Angel, P., Tschachler, E., & Wagner, E. F. (2005) · Nature · doi:10.1038/nature03963 · Cited by 599
Self-citationLiliensiek, B., Weigand, M. A., Bierhaus, A., Nicklas, W., Kasper, M., Hofer, S., Plachky, J., Gröne, H.-J., Kurschus, F. C., Schmidt, A. M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18704 · Cited by 524
Self-citationA novel pathway of HMGB1‐mediated inflammatory cell recruitment that requires Mac‐1‐integrin
Orlova, V. V., Choi, E. Y., Xie, C., Chavakis, E., Bierhaus, A., Ihanus, E., Ballantyne, C. M., Gahmberg, C. G., Bianchi, M. E., Nawroth, P. P., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601552 · Cited by 381
Self-citationTiano, H. F., Loftin, C. D., Akunda, J., Lee, C. A., Spalding, J. W., Sessoms, A. R., Dunson, D. B., Rogan, E. G., Morham, S. G., Smart, R. C., et al. (2002) · PubMed · Cited by 344
The chemokine receptor D6 limits the inflammatory response in vivo
Jamieson, T., Cook, D. N., Nibbs, R. J. B., Rot, A., Nixon, C., Mclean, P., Alcami, A., Lira, S. A., Wiekowski, M., & Graham, G. J. (2005) · Nature Immunology · doi:10.1038/ni1182 · Cited by 302
Constien, R., Forde, A., Liliensiek, B., Gröne, H., Nawroth, P., Hämmerling, G., & Arnold, B. (2001) · genesis · doi:10.1002/gene.1030 · Cited by 294
Self-citationHsu, T.-C., Young, M. R., Cmarik, J., & Colburn, N. H. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00220-3 · Cited by 265
Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis
Müller-Decker, K., Neufang, G., Berger, I., Neumann, M., Marks, F., & Fürstenberger, G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192323799 · Cited by 240
Shanmugam, N., Kim, Y. S., Lanting, L., & Natarajan, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302828200 · Cited by 192
Gender Differences in UVB-Induced Skin Carcinogenesis, Inflammation, and DNA Damage
Thomas‐Ahner, J. M., Wulff, B. C., Tober, K. L., Kusewitt, D. F., Riggenbach, J., & Oberyszyn, T. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3798 · Cited by 158
The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors
Nibbs, R. J. B., Gilchrist, D. S., King, V., Ferra, A., Forrow, S., Hunter, K. D., & Graham, G. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30068 · Cited by 149
S100B binding to RAGE in microglia stimulates COX-2 expression
Bianchi, R., Adami, C., Giambanco, I., & Donato, R. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306198 · Cited by 147
Gebhardt, C., Breitenbach, U., Tuckermann, J. P., Dittrich, B. T., Richter, K. H., & Angel, P. E. (2002) · Oncogene · doi:10.1038/sj.onc.1205521 · Cited by 127
Self-citationNF-κB inhibition: A double-edged sword in cancer?
Pikarsky, E., & Ben‐Neriah, Y. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.011 · Cited by 110
Posttranslationally Modified Proteins as Mediators of Sustained Intestinal Inflammation
Andrassy, M., Igwe, J. C., Autschbach, F., Volz, C., Remppis, A., Neurath, M. F., Schleicher, E. D., Humpert, P. M., Wendt, T., Liliensiek, B., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050713 · Cited by 95
Self-citationMüller‐Decker, K., Fürstenberger, G., Annan, N., Kucher, D., Pohl–Arnold, A., Steinbauer, B., Esposito, I., Chiblak, S., Friess, H., Schirmacher, P., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.053 · Cited by 57
Lumsden, J. M., Williams, J. A., & Hodes, R. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.2.781 · Cited by 51
c-Fos-Dependent Induction of the Small Ras-Related GTPase Rab11a in Skin Carcinogenesis
Gebhardt, C., Breitenbach, U., Richter, K. H., Fürstenberger, G., Mauch, C., Angel, P. E., & Heß, J. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62969-0 · Cited by 50
Self-citationMalignant progression of papillomas induced by the initiation-promotion protocol in NMRI mouse skin
Fürstenberger, G., & Kopp‐Schneider, A. (1995) · Carcinogenesis · doi:10.1093/carcin/16.1.61 · Cited by 48
Cited by
Natural Innate and Adaptive Immunity to Cancer
Vesely, M. D., Kershaw, M. H., Schreiber, R. D., & Smyth, M. J. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101324 · Cited by 2,101
Macrophage Polarization States in the Tumor Microenvironment
Boutilier, A. J., & Elsawa, S. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136995 · Cited by 1,631
Donato, R., R. Cannon, B., Sorci, G., Riuzzi, F., Hsu, K., J. Weber, D., & L. Geczy, C. (2013) · Current Molecular Medicine · doi:10.2174/156652413804486214 · Cited by 1,316
PAMP s and DAMP s: signal 0s that spur autophagy and immunity
Tang, D., Kang, R., Coyne, C. B., Zeh, H. J., & Lotze, M. T. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01146.x · Cited by 1,221
Kang, R., Chen, R., Zhang, Q., Hou, W., Wu, S., Cao, L., Huang, J., Yu, Y., Fan, X.-G., Yan, Z., et al. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.05.001 · Cited by 956
Metadata
- Authors
- Gebhardt, C., Riehl, A., Durchdewald, M., Németh, J., Fürstenberger, G., Müller-Decker, K., Enk, A., Arnold, B., Bierhaus, A., Nawroth, P. P., Hess, J., & Angel, P.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2008-01-21
- Volume
- 205
- Issue
- 2
- Pages
- 275-285
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2155756882
- Cited by
- 379
- References
- 35
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.